Cargando…
Therapeutic effects of rituximab combined with cyclophosphamide on refractory idiopathic thrombocytopenic purpura
Therapeutic effects of rituximab combined with cyclophosphamide on refractory idiopathic thrombocytopenic purpura (ITP) were investigated. We retrospectively analyzed 249 patients with refractory ITP who were admitted to Qingdao Hiser Medical Group between March 2013 and March 2017. Curative effects...
Autores principales: | Wang, Jiuhe, Wang, Bin, Sun, Zhonghui, Xue, Kezeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395969/ https://www.ncbi.nlm.nih.gov/pubmed/30867701 http://dx.doi.org/10.3892/etm.2019.7196 |
Ejemplares similares
-
Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab
por: Ahmed, Mohanad, et al.
Publicado: (2020) -
Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020) -
Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy
por: Musa, Faisal, et al.
Publicado: (2015) -
Idiopathic thrombocytopenic purpura
por: Kayal, L., et al.
Publicado: (2014) -
Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura: A case report
por: Chaurasiya, Prem Shankar, et al.
Publicado: (2022)